R P Anderson

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
    R P Anderson
    Institute of Molecular Medicine, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
    Nat Med 6:337-42. 2000

Collaborators

Detail Information

Publications1

  1. ncbi In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
    R P Anderson
    Institute of Molecular Medicine, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
    Nat Med 6:337-42. 2000
    ..Discovery of this dominant epitope may allow development of antigen-specific immunotherapy for CD...